Hyperion DeFi, Inc. is building a long-term strategic treasury of Hyperliquid's native token (HYPE) and provides investors with streamlined access to the Hyperliquid ecosystem. It is also developing its proprietary Optejet User Filled Device, designed for use with a variety of topical ophthalmic liquids, including artificial tears and lens rewetting products. The firm operates through the Ophthalmic Technology and Digital Assets segments. The Ophthalmic Technology segment focuses on developing eye-care devices and delivery systems for ophthalmic liquids. The Digital Assets segment focuses on managing a strategic treasury of blockchain-based assets and exposure to the Hyperliquid ecosystem. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in Laguna Hills, CA.
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, alerts, and much more.